€3.32
4.73% yesterday
Xetra, Jul 01, 05:36 pm CET
ISIN
DE0005495626
Symbol
GME
Sector

Geratherm Medical Target price 2025 - Analyst rating & recommendation

Geratherm Medical Classifications & Recommendation:

Buy
80%
Hold
20%

Geratherm Medical Price Target

Target Price €6.12
Price €3.32
Potential
Number of Estimates 3
3 Analysts have issued a price target Geratherm Medical 2026 . The average Geratherm Medical target price is €6.12. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 4 Analysts recommend Geratherm Medical to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Geratherm Medical stock has an average upside potential 2026 of . Most analysts recommend the Geratherm Medical stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Million € 13.98 18.18
33.30% 30.04%
EBITDA Margin 23.96% 15.00%
14.15% 37.40%
Net Margin 5.08% 0.90%
4.10% 82.28%

2 Analysts have issued a sales forecast Geratherm Medical 2025 . The average Geratherm Medical sales estimate is

€18.2m
Unlock
. This is
30.04% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€18.9m 35.19%
Unlock
, the lowest is
€17.6m 26.18%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 €14.0m 33.30%
2025
€18.2m 30.04%
Unlock
2026
€19.3m 6.11%
Unlock
2027
€17.5m 9.28%
Unlock

2 Analysts have issued an Geratherm Medical EBITDA forecast 2025. The average Geratherm Medical EBITDA estimate is

€2.7m
Unlock
. This is
20.26% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€2.8m 17.11%
Unlock
, the lowest is
€2.6m 22.63%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 €3.4m 23.86%
2025
€2.7m 18.60%
Unlock
2026
€3.1m 14.81%
Unlock
2027
€3.4m 7.31%
Unlock
2028
€2.7m 20.27%
Unlock
2029
€3.1m 14.82%
Unlock

EBITDA Margin

2024 23.96% 14.15%
2025
15.00% 37.40%
Unlock
2026
16.23% 8.20%
Unlock

2 Geratherm Medical Analysts have issued a net profit forecast 2025. The average Geratherm Medical net profit estimate is

€160k
Unlock
. This is
77.46% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€170k 76.06%
Unlock
, the lowest is
€160k 77.46%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 €710k 36.04%
2025
€160k 77.46%
Unlock
2026
€490k 206.25%
Unlock

Net Margin

2024 5.08% 4.10%
2025
0.90% 82.28%
Unlock
2026
2.55% 183.33%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share 0.13 0.03
38.10% 76.92%
P/E 104.62
EV/Sales 0.65

2 Analysts have issued a Geratherm Medical forecast for earnings per share. The average Geratherm Medical EPS is

€0.03
Unlock
. This is
72.73% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
€0.03 72.73%
Unlock
, the lowest is
€0.03 72.73%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 €0.13 38.10%
2025
€0.03 76.92%
Unlock
2026
€0.09 200.00%
Unlock
2027
€0.10 11.11%
Unlock

P/E ratio

Current 28.82 41.96%
2025
104.62 263.03%
Unlock
2026
34.87 66.67%
Unlock

Based on analysts' sales estimates for 2025, the Geratherm Medical stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.84 17.65%
2025
0.65 22.99%
Unlock
2026
0.61 5.77%
Unlock

P/S ratio

Current 1.30 23.72%
2025
1.00 23.11%
Unlock
2026
0.94 5.76%
Unlock

Current Geratherm Medical Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
MWB RESEARCH AG
Locked
Locked
Locked Nov 10 2024
Analyst Rating Date
Locked
MWB RESEARCH AG:
Locked
Locked
Nov 10 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today